NL8102168A - Theofyllinetablet met aanhoudende afgifte; werkwijze voor het handhaven van een therapeutisch effectieve bloedserumconcentratie van theofylline gedurende een uitgestrekte behandelperiode. - Google Patents

Theofyllinetablet met aanhoudende afgifte; werkwijze voor het handhaven van een therapeutisch effectieve bloedserumconcentratie van theofylline gedurende een uitgestrekte behandelperiode. Download PDF

Info

Publication number
NL8102168A
NL8102168A NL8102168A NL8102168A NL8102168A NL 8102168 A NL8102168 A NL 8102168A NL 8102168 A NL8102168 A NL 8102168A NL 8102168 A NL8102168 A NL 8102168A NL 8102168 A NL8102168 A NL 8102168A
Authority
NL
Netherlands
Prior art keywords
theophylline
tablet
pharmaceutical tablet
tablet according
hours
Prior art date
Application number
NL8102168A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8102168A publication Critical patent/NL8102168A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8102168A 1980-05-06 1981-05-01 Theofyllinetablet met aanhoudende afgifte; werkwijze voor het handhaven van een therapeutisch effectieve bloedserumconcentratie van theofylline gedurende een uitgestrekte behandelperiode. NL8102168A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14742980A 1980-05-06 1980-05-06
US14742980 1980-05-06
US24978781A 1981-04-01 1981-04-01
US24978781 1981-04-01

Publications (1)

Publication Number Publication Date
NL8102168A true NL8102168A (nl) 1981-12-01

Family

ID=26844921

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8102168A NL8102168A (nl) 1980-05-06 1981-05-01 Theofyllinetablet met aanhoudende afgifte; werkwijze voor het handhaven van een therapeutisch effectieve bloedserumconcentratie van theofylline gedurende een uitgestrekte behandelperiode.

Country Status (17)

Country Link
AT (1) AT380789B (enrdf_load_stackoverflow)
AU (1) AU549299B2 (enrdf_load_stackoverflow)
CA (1) CA1165241A (enrdf_load_stackoverflow)
CY (1) CY1368A (enrdf_load_stackoverflow)
DE (1) DE3117756A1 (enrdf_load_stackoverflow)
DK (1) DK155976C (enrdf_load_stackoverflow)
FI (1) FI811356A7 (enrdf_load_stackoverflow)
FR (1) FR2484253A1 (enrdf_load_stackoverflow)
GB (1) GB2078518B (enrdf_load_stackoverflow)
HK (1) HK4288A (enrdf_load_stackoverflow)
IE (1) IE51157B1 (enrdf_load_stackoverflow)
IT (1) IT1209867B (enrdf_load_stackoverflow)
KE (1) KE3722A (enrdf_load_stackoverflow)
LU (1) LU83342A1 (enrdf_load_stackoverflow)
NL (1) NL8102168A (enrdf_load_stackoverflow)
SE (1) SE452550B (enrdf_load_stackoverflow)
SG (1) SG30987G (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
FR2595945B1 (fr) * 1986-03-19 1990-01-19 Doms Laboratoires Comprime-retard de theophylline a base de p.v.c., et son procede de preparation
USD557612S1 (en) * 2006-04-10 2007-12-18 Parfums Christian Dior Flask for a cosmetic product

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636568A (enrdf_load_stackoverflow) * 1961-01-31
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion

Also Published As

Publication number Publication date
SE8102814L (sv) 1981-11-07
DK200181A (da) 1981-11-07
FI811356L (fi) 1981-11-07
SE452550B (sv) 1987-12-07
DE3117756A1 (de) 1982-04-29
DK155976B (da) 1989-06-12
KE3722A (en) 1987-04-30
LU83342A1 (fr) 1982-01-20
DK155976C (da) 1989-10-30
SG30987G (en) 1987-07-17
IE51157B1 (en) 1986-10-15
GB2078518A (en) 1982-01-13
FR2484253B1 (enrdf_load_stackoverflow) 1983-06-03
CA1165241A (en) 1984-04-10
HK4288A (en) 1988-01-29
GB2078518B (en) 1984-04-11
FR2484253A1 (fr) 1981-12-18
AU7020581A (en) 1981-11-12
FI811356A7 (fi) 1981-11-07
IT8148406A0 (it) 1981-05-06
IE810989L (en) 1981-11-06
CY1368A (en) 1987-08-07
AT380789B (de) 1986-07-10
AU549299B2 (en) 1986-01-23
ATA202081A (de) 1985-12-15
IT1209867B (it) 1989-08-30
DE3117756C2 (enrdf_load_stackoverflow) 1992-11-26

Similar Documents

Publication Publication Date Title
US4465660A (en) Sustained release tablet containing at least 95 percent theophylline
Bernardi et al. Effects of prolonged ingestion of graded doses of licorice by healthy volunteers
KR101558938B1 (ko) Ｄｐｐ-ｉｖ 억제제의 용도
RU2144353C1 (ru) Кофеинсодержащие композиции продолжительного действия
US20050147672A1 (en) Tablets quickly disintegrating in mouth
NO338714B1 (no) Generelt lineær, brusende, oral fentanyl doseringsform som er egnet for administrering av fentanyl over en pasients orale slimhinner ved bukkal, gingival eller sublingval administrering, og fremgangsmåter for fremstilling derav.
JP2007326876A (ja) オーバーコートしたチューインガム配合物
MX2011009629A (es) Coposiciones farmaceuticas de liberacion inmediata que comprende oxicodona y naloxona.
KR20110112266A (ko) 활성 성분의 방출을 조절할 수 있는 가분성 생약 형태
Woodford et al. Relative bioavailability of aspirin gum
KR20200070246A (ko) 이중층 제약 정제 제제
NL8102168A (nl) Theofyllinetablet met aanhoudende afgifte; werkwijze voor het handhaven van een therapeutisch effectieve bloedserumconcentratie van theofylline gedurende een uitgestrekte behandelperiode.
US9308212B2 (en) Compositions comprising alprazolam for treating primary insomnia and insomnia associated with anxiety states and process for preparing them
HUE030609T2 (en) New pharmaceutical compositions for the treatment of insomnia
Patil et al. A review on mouth dissolving tablet
DK144261C (da) Medicinsk tablet indeholdende allopurinol
Pandurangan et al. Fast dissolving tablets–an overview
Paul et al. FORMULATION AND EVALUATION OF METFORMIN HYDROCHLORIDE ORO-DISPERSIBLE TABLETS
Shivprasad et al. Formulation and evaluation of fast dispersible tablets of Aceclofenac
Tambe Formulation and Evaluation of Paracetamol Effervescent Tablet
JP2005289906A (ja) 医薬組成物
Patidar et al. A COMPREHENSIVE REVIEW ON MOUTH DISSOLVING TABLET
JPH0136444B2 (enrdf_load_stackoverflow)
Jadhav et al. Review on Formulation and Evaluation of Fast-dissolving tablets of Rizatriptan Benzoate using different Super Disintegrants.
Rajesh et al. Formulation and evaluation of fast dissolving tablet of Pioglitazone

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BN A decision not to publish the application has become irrevocable